Filing Details
- Accession Number:
- 0001640334-22-000206
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2022-01-31 13:58:22
- Reporting Period:
- 2021-12-31
- Accepted Time:
- 2022-01-31 13:58:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516551 | Skye Bioscience Inc. | SKYE | Pharmaceutical Preparations (2834) | 450692882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1728413 | Emerald Health Sciences Inc. | Office 8262 The Landing, 200-375 Water St. Vancouver A1 V6B 0M9 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-08-07 | 2,566,666 | $0.10 | 111,387,251 | No | 5 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants with Credit Facility of Oct 5, 2018 | Acquisiton | 2018-11-01 | 2,500,000 | $0.00 | 2,500,000 | $0.50 |
| Common Stock | Warrants with Credit Facility of Oct 5, 2018 | Acquisiton | 2019-02-01 | 2,500,000 | $0.00 | 2,500,000 | $0.50 |
| Common Stock | Warrants with Credit Facility of Oct 5, 2018 | Acquisiton | 2019-03-29 | 2,500,000 | $0.00 | 2,500,000 | $0.50 |
| Common Stock | Multi Draw Credit Facility - T2 | Acquisiton | 2019-02-01 | 38,822 | $0.00 | 38,822 | $0.40 |
| Common Stock | Multi Draw Credit Facility - T3 | Acquisiton | 2019-03-29 | 5,354,861 | $0.00 | 5,354,861 | $0.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,500,000 | 2018-11-01 | 2023-11-01 | No | 5 | A | Direct |
| 2,500,000 | 2019-02-01 | 2024-02-01 | No | 5 | A | Direct |
| 2,500,000 | 2019-03-29 | 2024-03-29 | No | 5 | A | Direct |
| 38,822 | 2022-10-05 | 2022-10-05 | No | 5 | A | Direct |
| 5,354,861 | 2022-10-05 | 2022-10-05 | No | 5 | A | Direct |
Footnotes
- Transactions were previously reported on various prior Form 4 filings; however, the entries were erroneously reported as non-derivative transactions in Common Stock and the resulting reported total ownership included the misclassified securities. The entry of these transactions is to correct this error and reflect the actual securities held by the Reporting Person.
- The Multi Draw Credit Facility tranches have the option to convert into Common Stock upon maturity of the facilities.
Billionaire Hedge Funds
